DSM-Firmenich stock follows completion of EUR 540 million buyback

Published on 10/05/2026 at 13:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich stock traded at EUR 96.94 on October 5, 2026, while its EUR 540 million repurchase reached completion. First-half revenue was EUR 4.664 billion and adjusted EBITDA was EUR 900 million.

Börsen-Editorialfoto vom Trading-Floor mit Charts und Molekülgrafiken — dsm-firmenich AG (ISIN CH1216478797) notiert an der SIX, als Editorial-Szene vom Börsen-Trading-Floor mit Charts dargestellt, Illustration mit AI erstellt.

DSM-Firmenich (ISIN CH1216478797) traded at EUR 96.94 on Euronext Amsterdam at 12:51 p.m. CEST on October 5, 2026, up 0.81 percent from the previous close. The latest company action is the completed EUR 540 million share repurchase program announced by dsm-firmenich on October 1, 2026.

EUR 540 million buyback is complete

The program repurchased 7,169,147 shares at an average price of EUR 75.32, according to dsm-firmenich. Of that total, 6,488,446 shares were acquired for capital reduction, while 680,701 shares cover commitments under share-based compensation plans.

The company intends to cancel the capital-reduction shares by the end of the first quarter of 2027. That would reduce issued shares from 253,626,947 to 247,138,501, a 2.6 percent reduction based on the company figures.

First-half margin reaches 19.3 percent

DSM-Firmenich reported EUR 4.664 billion of continuing-operations revenue for the first half of 2026 and adjusted EBITDA of EUR 900 million, according to De Belegger. The adjusted EBITDA margin was 19.3 percent for the half year and 19.5 percent in the second quarter.

Comparable revenue growth reached 5 percent in the first half and 6 percent in the second quarter. The same report states that core adjusted EPS rose 14 percent to EUR 1.84, while first-half gross cash conversion was 7 percent against a full-year company target of 11 percent to 12 percent.

Analyst targets stay near the price

Consensus data published by Fintel on September 16, 2026 showed a mean price target of EUR 95.74 and a median of EUR 96.90. The recommendation set included 31 analysts, with 6 strong buy, 14 buy, 8 hold, 2 sell and 1 strong sell ratings.

Fintel also reported that Equita SIM cut DSM-Firmenich from Buy to Hold on September 18, 2026. BNP Paribas later moved from Outperform to Neutral with a EUR 100 price target on October 2, 2026, as reported by Markets Insider.

Stock remains below its yearly high

At EUR 96.94 on October 5, 2026, DSM-Firmenich was EUR 2.46 below its 52-week high of EUR 99.40 and above its 52-week low of EUR 55.22. The market capitalization was EUR 23.9 billion on the same date.